Harmony Biosciences Holdings, Inc. HRMY
34.42 USD -2.61 (-7.04%)
At closeNov 5, 2026, 7:07 AM EST
33.05 -1.37 -3.97%
Pre-market · Nov 5, 7:07 AM ET
32.61 Day range 35.86
25.90 52-week range 43.49
- YTD
- -8.03%
- 1 year
- +9.78%
Analyst view
Consensus: buy
Buy
Price target (mean) 48.08 +39.7% upside
Now 34.42
- Target (low)
- 30.00
- Target (mean)
- 48.08
- Target (high)
- 70.00
Ratings (0m) 12 8 buy · 3 hold · 1 sell
- Strong buy2
- Buy6
- Hold3
- Sell0
- Strong sell1
Recommendation trend
- This month 12
- 1 month ago 11
- 2 months ago 11
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 1.53 | 1.45 – 1.60 | 0.57 | +168.0% | 280.05M | +14.9% | 2 |
| Next quarter | 0.8275 | 0.71 – 0.94 | 0.55 | +50.5% | 256.69M | +19.2% | 4 |
| Current year | 5.22 | 5.13 – 5.31 | 3.60 | +45.0% | 1.03B | +18.2% | 2 |
| Next year | 7.00 | 6.98 – 7.03 | 5.22 | +34.1% | 1.17B | +13.7% | 2 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 19, 2026 | Needham | Reiterated | Buy | Buy |
| Oct 13, 2026 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Oct 12, 2026 | Needham | Reiterated | Buy | Buy |
| Aug 26, 2026 | Wolfe Research | Initiated | — | Outperform |
| Aug 5, 2026 | Truist Securities | Maintained | Hold | Hold |
| Aug 4, 2026 | Needham | Maintained | Buy | Buy |
| Jul 31, 2026 | Mizuho | Maintained | Outperform | Outperform |
| Jul 16, 2026 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jun 30, 2026 | Deutsche Bank | Maintained | Hold | Hold |
| May 8, 2026 | Truist Securities | Maintained | Hold | Hold |
| Feb 25, 2026 | UBS | Maintained | Neutral | Neutral |
| Feb 25, 2026 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Feb 25, 2026 | B of A Securities | Maintained | Underperform | Underperform |
| Feb 25, 2026 | Needham | Maintained | Buy | Buy |
| Feb 11, 2026 | UBS | Downgrade | Buy | Neutral |
| Jan 8, 2026 | Truist Securities | Maintained | Buy | Buy |
| Dec 1, 2025 | Mizuho | Maintained | Outperform | Outperform |
| Nov 24, 2025 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Nov 24, 2025 | Needham | Reiterated | Buy | Buy |
| Nov 6, 2025 | Mizuho | Maintained | Outperform | Outperform |
| Oct 15, 2025 | UBS | Maintained | Buy | Buy |
| Sep 25, 2025 | Mizuho | Maintained | Outperform | Outperform |
| Sep 25, 2025 | Deutsche Bank | Maintained | Buy | Buy |
| Sep 25, 2025 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Sep 24, 2025 | Needham | Maintained | Buy | Buy |
| Jul 21, 2025 | Truist Securities | Initiated | — | Buy |
| Jul 10, 2025 | Deutsche Bank | Maintained | Buy | Buy |
| May 15, 2025 | Mizuho | Maintained | Outperform | Outperform |
| May 7, 2025 | Needham | Reiterated | Buy | Buy |
| May 6, 2025 | Needham | Reiterated | Buy | Buy |